Recombinant Alpaca Anti-IAV NP Single Domain Antibody (PABC-575) (CAT#: PABC-575)

This product is a recombinant Alpaca antibody that can recognize IAV NP. αNP-VHH1, blocks vRNP nuclear import, viral transcription, and replication in a similar fashion as do interferon-induced, antiviral Mx proteins. αNP-VHH1 binds to the NP body domain.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Published Data
  • Datasheet
  • MSDS
  • COA
IB

Figure 1 VHHs isolated from the influenza virus VHH library are specific for NP.

Figure 1 VHHs isolated from the influenza virus VHH library are specific for NP.

His-tagged NP was incubated briefly with His-tagged versions of the given VHHs. Biotinylated NP-VHH1 immobilized on streptavidin beads was then used to pull down NP-His. Precipitated protein was run on SDS-PAGE and detected via immunoblotting with His-HRP antibody.

Ashour, J., Schmidt, F. I., Hanke, L., Cragnolini, J., Cavallari, M., Altenburg, A., ... & Ploegh, H. L. (2015). Intracellular expression of camelid single-domain antibodies specific for influenza virus nucleoprotein uncovers distinct features of its nuclear localization. Journal of virology, 89(5), 2792-2800.

IP

Figure 2 Expression of NP-VHH-Ch in MDCK cells results in decreased influenza virus expression upon virus challenge.

Figure 2 Expression of NP-VHH-Ch in MDCK cells results in decreased influenza virus expression upon virus challenge.

MDCK cells stably expressing VHH-Ch were challenged with influenza virus (MOI, 1.0). Two hours postinfection, cells were metabolically labeled with [³⁵S]methionine for 20 min. Cells were lysed in NP-40-containing lysis buffer, and the lysate was subsequently probed with WSN serum and FluB1 antibody. Samples were analyzed by SDS-PAGE and autoradiography.

Ashour, J., Schmidt, F. I., Hanke, L., Cragnolini, J., Cavallari, M., Altenburg, A., ... & Ploegh, H. L. (2015). Intracellular expression of camelid single-domain antibodies specific for influenza virus nucleoprotein uncovers distinct features of its nuclear localization. Journal of virology, 89(5), 2792-2800.

WB

Figure 3 NP-VHH2 and -4 do not influence NP activity in a mini-genome assay.

Figure 3 NP-VHH2 and -4 do not influence NP activity in a mini-genome assay.

293T cellsweretransfectedwith plasmids expressing influenza virus PB1, PB2, PA, NP, and VHH-Ch and a plasmid transcribing a model genome segment encoding neuraminidase with a sortag motif inserted at the C terminus (NAsrt) (under the control of the pPol1 promoter). At 24 h posttransfection, cells were lysed in NP-40-containing lysis buffer. Samples were analyzed via Western blotting using antibody against the HA epitope, NP, mCherry, and GAPDH.

Ashour, J., Schmidt, F. I., Hanke, L., Cragnolini, J., Cavallari, M., Altenburg, A., ... & Ploegh, H. L. (2015). Intracellular expression of camelid single-domain antibodies specific for influenza virus nucleoprotein uncovers distinct features of its nuclear localization. Journal of virology, 89(5), 2792-2800.

Inhib

Figure 4 NP-VHH1 impairs influenza A virus replication at early and late time points.

Figure 4 NP-VHH1 impairs influenza A virus replication at early and late time points.

A549 cells expressing αNP-VHH1-HA in a doxycycline (Dox)-inducible manner were seeded 24 h before influenza A virus (IAV) infection. VHH expression was induced at the indicated time points relative to infection; cells were infected with IAV at an MOI of 1 at t=0 h. Cells were harvested 6 h postinfection (p.i.), stained for HA and NP, and analyzed by flow cytometry. Geometric mean of anti-HA-Alexa Fluor 488 (VHH expression level, red) and fraction of infected cells (NP positive, gray) are shown.

Hanke, L., Knockenhauer, K. E., Brewer, R. C., van Diest, E., Schmidt, F. I., Schwartz, T. U., & Ploegh, H. L. (2016). The antiviral mechanism of an influenza A virus nucleoprotein-specific single-domain antibody fragment. MBio, 7(6), e01569-16.

Inhib

Figure 5 Inhibition of polymerase activity by NP-VHH1 and Mx1 is dependent on transcript length.

Figure 5 Inhibition of polymerase activity by NP-VHH1 and Mx1 is dependent on transcript length.

293T cells were transfected with expression vectors for influenza virus A/WSN/33 PA, PB1, PB2, and NP, as well as the indicated VHHs or Mx proteins. In addition, we cotransfected plasmid pPolI-RT, from which a synthetic genome segment was transcribed which encoded either EGFP (720 nt) or mCherry-T2A-EGFP (1,500 nt). Twenty-four hours posttransfection, EGFP-positive cells were quantified by flow cytometry. Since reduced EGFP levels were expressed from the mCherry-T2A-EGFP construct, values were normalized to EGFP-positive cells expressing VHH7 (control).

Hanke, L., Knockenhauer, K. E., Brewer, R. C., van Diest, E., Schmidt, F. I., Schwartz, T. U., & Ploegh, H. L. (2016). The antiviral mechanism of an influenza A virus nucleoprotein-specific single-domain antibody fragment. MBio, 7(6), e01569-16.


Specifications

  • Host Species
  • Alpaca
  • Type
  • Alpaca VHH
  • Specificity
  • IAV NP
  • Species Reactivity
  • IAV
  • Clone
  • PABC-575
  • Applications
  • Inhib, IP, Neut, WB, FC, IF, IB
  • Related Disease
  • Infectious disease

Product Property

  • Purity
  • >95% as determined by analysis by SDS-PAGE
  • Storage
  • Store at -20°C for long-term storage. Avoid freeze/thaw cycles.

Applications

  • Application Notes
  • The antibody was validated for Inhibition, Western Blot, Neutralization, Immunoprecipitation, Flow Cytometry, Immunofluorescence, Immunoblotting. For details, refer to Published Data.

Target

  • Alternative Names
  • IAV NP; Influenza A Virus Nucleoprotein

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "IAV NP"

Intrabody

CAT Product Name Application Type
IAB-B040(A) Recombinant Anti-IAV NP Intrabody [(D-Arg)9] WB, Neut, FuncS scFv-(D-Arg)9
IAB-B040(G) Recombinant Anti-IAV NP Intrabody [+36 GFP] WB, ICC, Neut, FuncS scFv-(+36GFP)
IAB-B040(T) Recombinant Anti-IAV NP Intrabody [Tat] IF, FC, FuncS scFv-Tat

Recombinant Antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for PABC-575. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare